Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | OMX-0407 |
| Trade Name | |
| Synonyms | OMX 0407|OMX0407 |
| Drug Descriptions |
OMX-0407 inhibits salt-inducible kinase 3 (SIK3), potentially leading to tumor cell death, enhanced antitumor immune response, and inhibition of tumor growth (Cancer Res (2023) 83 (7_Supplement): 953, Cancer Res (2022) 82 (12_Supplement): 3708). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| OMX-0407 | OMX-0407 | 0 | 1 |